Two professionals in discussion before a Candid Therapeutics wall logo in a corporate office setting

PARTNERSHIPS

2 Jun 2026

Can T-Cell Science Fix What Biologics Cannot?

UCB acquires Candid Therapeutics for up to $2.2B, betting T-cell engager science can reset autoimmune disease, not just manage it

BD red starburst logo and blue company name on the upper facade of a modern silver-clad office building

TECHNOLOGY

27 May 2026

Hospitals Tap Sovereign Cloud Into the Future of Medicine

Becton Dickinson deploys its intelligent Pyxis Pro and Incada cloud network to secure hospital workflows and eliminate dosing errors

EMA blue logo and signage on office building

PARTNERSHIPS

28 Apr 2026

Can a Biosimilar Finally Make Macular Care Affordable?

The EMA has recommended Rexatilux for approval, offering an affordable new biosimilar for treating age-related macular degeneration across...

Blue gloved hand holding transparent cell culture plate in lab

PARTNERSHIPS

14 Apr 2026

Vertex Licenses Its Way Into Smarter Injections

Vertex pays $15M upfront to license Halozyme's Hypercon platform, aiming to make high-concentration biologic injections possible at home

Researchers reviewing brain scan images on medical monitor in lab

INVESTMENT

23 Feb 2026

Cracking the Brain’s Code: Aerska’s $39M Leap

Aerska lands $39M to deliver RNA into the brain, signaling biotech’s next big frontier

Scientist preparing intranasal drug formulation in laboratory

RESEARCH

13 Feb 2026

Nose Knows: A New Route Into the Brain

Intranasal nanocarriers aim to slip past the brain’s defenses and reshape treatment for neurological disease

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.